

AI is everywhere in the product. But revenue growth is decelerating, from 16% to 13% to 12% guided. The productivity benefits are arriving for users and end-consumers of AI, though it's not hitting the income statement (at least yet) for most companies.

Investors chasing pre-IPO SpaceX exposure through an ETF wrapper usually narrow the field to two names: ERShares Private-Public Crossover ETF (NASDAQ:XOVR) and the ARK Innovation ETF (NYSEARCA:ARKK).

Ark Investʻs Cathie Wood has been loading up on shares of CoreWeave stock. The AI stock has been tanking in recent weeks.

The ARK Innovation ETF (NYSEARCA:ARKK) remains one of the most recognizable thematic funds on the market, marketed as a bet on disruptive innovation across AI, genomics, fintech, and autonomous technology.

The famed portfolio manager was busy buying stocks on pullbacks recently.

The defined outcome ETF market, commonly known as buffer ETFs, has grown rapidly in popularity over the last few years, as investors look for funds that explicitly protect against downside risks. In 2022, the stock and bond markets saw a major decline.

The ARK Innovation ETF (NYSEARCA:ARKK) has barely moved this year, gaining about 2% year to date through late June and sitting at roughly $78 per share.

Cathie Wood's Ark Innovation Fund (ARKK) ETF stock has remained inside a narrow range in the past few months. ARKK has remained between the support and resistance levels at $72.68 and $82.35 since April.